Shell’s mega-merger with BG

Oil and gas giant Shell's £47bn takeover of rival BG Group marks the world’s biggest deal so far this year.

737-BG-group
Caution has merged with buccaneering

Oil and gas giant Shell is to buy rival BG Group for £47bn in cash and shares, marking the world's biggest deal so far this year and a 50% premium to BG's pre-bid share price. BG shareholders will own 19% of the group, which will be the world's second-biggest oil and gas company after Exxon Mobil.

What the commentators said

Shell will be able to add more than 25% to its "ailing 13 billion barrel reserve base" it has only replaced 80% of the reserves it has consumed in the last three years. Its production will grow by a fifth. But Shell is paying a high price, said Lex, and is counting on $90 oil in a few years' time to keep its promises. Whether this is plausible "is unclear". Managers "will have their work cut out to execute the deal", generate cost-cuts and synergies, and secure asset sales. "The risk of indigestion is not small."

Most takeovers fail to deliver the promised gains in value, added Nick Butler in the FT, often due to cultural differences. "It will be fascinating to watch the integration of Shell's ultra-cautious committee structure with BG's highly personal buccaneering style." More broadly, expect more deals now that the industry has realised low prices could persist, and restructuring is on the agenda for everyone. "The Shell deal is just the beginning."

Recommended

Bill Ackman: beware of short-term market volatility
Investment gurus

Bill Ackman: beware of short-term market volatility

Bill Ackman, founder of the Pershing Square hedge fund, is upbeat on prospects for markets in 2021, but is worried about short-term volatility as coro…
27 Nov 2020
More good news as AstraZeneca finds a third Covid vaccine
Biotech stocks

More good news as AstraZeneca finds a third Covid vaccine

Another week, another Covid-19 vaccine. This one from AstraZeneca and Oxford University is homegrown and ready to roll out fast. Matthew Partridge rep…
26 Nov 2020
Stockmarkets remain unimpressed by news of the latest vaccine
Stockmarkets

Stockmarkets remain unimpressed by news of the latest vaccine

Stockmarkets went mad on news of Pfizer’s Covid-19 vaccine, but a similar update from AstraZeneca brought little more than a shrug.
26 Nov 2020
Investors’ “smart money” heads for emerging markets
Emerging markets

Investors’ “smart money” heads for emerging markets

With Asia having dodged the worst of the pandemic and stockmarkets and the Regional Comprehensive Economic Partnership promising a bright future, Wes…
20 Nov 2020

Most Popular

The next 20 years: five new technologies on the horizon
Global Economy

The next 20 years: five new technologies on the horizon

What will everyday life be like in two decades’ time? Matthew Partridge peers into his crystal ball.
12 Nov 2020
This week’s rally in value stocks is just the beginning
Value investing

This week’s rally in value stocks is just the beginning

The arrival of a vaccine this week saw huge gains in the markets and investors switching out of big-tech growth stocks and into “value” stocks in more…
13 Nov 2020
Share tips of the week
Share tips

Share tips of the week

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
13 Nov 2020